Dow Down0.65% Nasdaq Down1.22%

More On ANPMF

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Angiotech Pharmaceuticals Inc. (ANPMF)

-Other OTC
25.00 0.00(0.00%) Mar 28
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
0-00-31
Next Qtr.
0-00-31
Current Year
0-00-31
Next Year
0-00-31
Avg. EstimateN/AN/AN/AN/A
No. of AnalystsN/AN/AN/AN/A
Low EstimateN/AN/AN/AN/A
High EstimateN/AN/AN/AN/A
Year Ago EPSN/AN/AN/AN/A
Revenue EstCurrent Qtr.
0-00-31
Next Qtr.
0-00-31
Current Year
0-00-31
Next Year
0-00-31
Avg. EstimateNaNNaNNaNNaN
No. of Analysts
Low EstimateNaNNaNNaNNaN
High EstimateNaNNaNNaNNaN
Year Ago SalesNaNNaNNaNNaN
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History
EPS EstN/AN/AN/AN/A
EPS ActualN/AN/AN/AN/A
DifferenceN/AN/AN/AN/A
Surprise %N/AN/AN/AN/A
EPS TrendsCurrent Qtr.
0-00-31
Next Qtr.
0-00-31
Current Year
0-00-31
Next Year
0-00-31
Current EstimateN/AN/AN/AN/A
7 Days AgoN/AN/AN/AN/A
30 Days AgoN/AN/AN/AN/A
60 Days AgoN/AN/AN/AN/A
90 Days AgoN/AN/AN/AN/A
EPS RevisionsCurrent Qtr.
0-00-31
Next Qtr.
0-00-31
Current Year
0-00-31
Next Year
0-00-31
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstANPMFIndustrySectorS&P 500
Current Qtr.N/AN/A-76.10%13.60%
Next Qtr.N/AN/A-65.30%23.90%
This YearN/AN/A46.50%7.70%
Next YearN/AN/A34.80%13.00%
Past 5 Years (per annum)-77.64%N/AN/AN/A
Next 5 Years (per annum)70.00%14.22%16.13%10.15%
Price/Earnings (avg. for comparison categories)N/A3.076.2228.99
PEG Ratio (avg. for comparison categories)N/A1.148.682.41
Currency in USD.